BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24745881)

  • 1. Setting the record straight: the origin of the pharmacophore concept.
    Güner OF; Bowen JP
    J Chem Inf Model; 2014 May; 54(5):1269-83. PubMed ID: 24745881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
    Sörgel F
    Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple idea to generate fragment and pharmacophore descriptors and their implications in chemical informatics.
    Catana C
    J Chem Inf Model; 2009 Mar; 49(3):543-8. PubMed ID: 19243168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
    J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel method for pharmacophore analysis by examining the joint pharmacophore space.
    Ranu S; Singh AK
    J Chem Inf Model; 2011 May; 51(5):1106-21. PubMed ID: 21488651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational and efficient geometric definition of pharmacophores is essential for the patent process.
    Guérin GA; Pratuangdejkul J; Alemany M; Launay JM; Manivet P
    Drug Discov Today; 2006 Nov; 11(21-22):991-8. PubMed ID: 17055408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concept and terminology study on Xiahe points (lower confluent point)].
    Zhao JS; Shi XD
    Zhongguo Zhen Jiu; 2010 Dec; 30(12):1035-7. PubMed ID: 21290846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models for biological research: the theory and practice of Paul Ehrlich.
    Travis AS
    Hist Philos Life Sci; 2008; 30(1):79-97. PubMed ID: 19203012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Modeling: From Paul Ehrlich's Dyes to
    Travis AS
    J Comput Biol; 2019 Jul; 26(7):726-734. PubMed ID: 31066580
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing specificity and sensitivity of pharmacophore-based virtual screening by incorporating chemical and shape features--a case study of HIV protease inhibitors.
    Pandit D; So SS; Sun H
    J Chem Inf Model; 2006; 46(3):1236-44. PubMed ID: 16711743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paul Ehrlich and the Early History of Granulocytes.
    Kay AB
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
    Giangreco I; Cosgrove DA; Packer MJ
    J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
    Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
    J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self-organizing algorithm for molecular alignment and pharmacophore development.
    Bandyopadhyay D; Agrafiotis DK
    J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation.
    Cross S; Baroni M; Goracci L; Cruciani G
    J Chem Inf Model; 2012 Oct; 52(10):2587-98. PubMed ID: 22970894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.